In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AZ out-licenses cardio drug rights to CMS, Tibet Rhodiola; gets $500mm

Executive Summary

AstraZeneca PLC off-loaded rights for two cardiovascular drugs to China Medical System Holdings Ltd. (CMS) and one of its affiliates, Tibet Rhodiola Pharmaceutical Holding Co. (Tibet Rhodiola is minority-owned by CMS, which is its largest shareholder.)
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Marketing (Licensing)
    • Reverse Licensing

Related Companies